title: A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation.
abstract: The increased use of hematopoietic progenitor cell (HPC) transplantation has implications and consequences for transfusion services: not only in hospitals where HPC transplantations are performed, but also in hospitals that do not perform HPC transplantations but manage patients before or after transplantation. Candidates for HPC transplantation have specific and specialized transfusion requirements before, during, and after transplantation that are necessary to avert the adverse consequences of alloimmunization to human leukocyte antigens, immunohematologic consequences of ABO-mismatched transplantations, or immunosuppression. Decisions concerning blood transfusions during any of these times may compromise the outcome of an otherwise successful transplantation. Years after an HPC transplantation, and even during clinical remission, recipients may continue to be immunosuppressed and may have critically important, special transfusion requirements. Without a thorough understanding of these special requirements, provision of compatible blood components may be delayed and often urgent transfusion needs prohibit appropriate consultation with the patient's transplantation specialist. To optimize the relevance of issues and communication between clinical hematologists, transplantation physicians, and transfusion medicine physicians, the data and opinions presented in this review are organized by sequence of patient presentation, namely, before, during, and after transplantation.
authors.affiliation: Department of Medicine, Temple University, Philadelphia, PA, USA. gajewski@ohsu.edu
authors.forename: James L
authors.initials: JL
authors.lastname: Gajewski
authors.forename: Viviana V
authors.initials: VV
authors.lastname: Johnson
authors.forename: S Gerald
authors.initials: SG
authors.lastname: Sandler
authors.forename: Antoine
authors.initials: A
authors.lastname: Sayegh
authors.forename: Thomas R
authors.initials: TR
authors.lastname: Klumpp
mesh_terms: D001781:Blood Component Removal; D001792:Blood Platelets / Q000166:cytology; D001803:Blood Transfusion / Q000379:methods*; D002986:Clinical Trials as Topic; D003586:Cytomegalovirus Infections / Q000635:transmission; D004912:Erythrocytes / Q000166:cytology; D005720:Gamma Rays; D006405:Hematology / Q000379:methods; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006412:Hematopoietic Stem Cells / Q000166:cytology*; D006801:Humans; D007107:Immune System; D008495:Medical Oncology / Q000379:methods; D013156:Splenectomy